tiprankstipranks
Trending News
More News >
Aprea Therapeutics Inc (APRE)
NASDAQ:APRE
US Market

Compare Aprea Therapeutics (APRE) vs. Competitors

Compare
491 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Aprea Therapeutics
$0.80
$5.57M
-0.37
-79.05%
2 Buy
0 Hold
0 Sell
Moderate Buy
Eterna Therapeutics
$1.22
$9.58M
-0.26
-77.80%
Quoin Pharmaceuticals
$11.72
$4.24M
-0.02
-28.64%
1 Buy
0 Hold
0 Sell
Moderate Buy
Nucana
$3.33
$10.45M
-0.02
-98.78%
VYNE Therapeutics
$0.57
$18.84M
-0.72
-76.02%
1 Buy
1 Hold
0 Sell
Moderate Buy
IN8bio
$1.97
$19.24M
-0.30
-73.51%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
APRE
Aprea Therapeutics
0.80
-3.03
-79.19%
ERNA
Eterna Therapeutics
1.22
-4.20
-77.49%
QNRX
Quoin Pharmaceuticals
7.22
-3.11
-30.09%
NCNA
Nucana
2.51
-191.49
-98.71%
VYNE
VYNE Therapeutics
0.57
-1.75
-75.60%
INAB
IN8bio
1.97
-5.56
-73.84%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts